PI4KB and neoplasm: In this in vitro tumor model, PI4KB-Peptide-1 expression in combination with trametinib dramatically blocked tumor growth, achieving equivalent (SW620) or superior (HCT116) tumor inhibitory effects to chloroquine combined with trametinib (Fig. 9a–c).